Share Price:

APNASPENAspen Pharmacare Hldgs210740 (0.00%)

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform to be released on 4 March 2024.

Aspen confirms non-binding term sheet on manufacture and sale of an Aspen- branded COVID-19 vaccine throughout Africa

Durban, South Africa – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, is pleased to confirm that one of its wholly-owned South African subsidiaries, Aspen SA Operations (Pty) Limited (“Aspen SA”), has confirmed a non-binding term sheet with Janssen Pharmaceuticals, Inc., and Janssen Pharmaceutica NV, two of the Janssen… Continue reading Aspen confirms non-binding term sheet on manufacture and sale of an Aspen- branded COVID-19 vaccine throughout Africa

Aspen welcomes Kenyan President Uhuru Kenyatta to its Gqeberha manufacturing site

Aspen Chairman Kuseni Dlamini (far left) welcoming Kenyan President His Excellency President Uhuru Kenyatta (centre) together with Aspen’s Stavros Nicolaou, Senior Executive Strategic Trade (far right)

Gqeberha, South Africa – Aspen, a global multinational specialty pharmaceutical company, earlier today welcomed Kenyan President, His Excellency President Uhuru Kenyatta, to its world class flagship manufacturing site in Gqeberha. President Kenyatta’s visit to Aspen forms part of a broader collaboration and deepening of ties between South Africa and Kenya to lessen Africa’s dependence on… Continue reading Aspen welcomes Kenyan President Uhuru Kenyatta to its Gqeberha manufacturing site

Minister Ebrahim Patel opens Aspen’s world class general anaesthetic manufacturing line

Stephen Saad, Aspen Group Chief Executive (left) and Honorable Minister of Trade, Industry and Competition, Mr Ebrahim Patel at the unveiling of Aspen's general anaesthetics manufacturing line in Gqeberha, South Africa

Gqeberha, South Africa – Aspen, a global multinational specialty pharmaceutical company, earlier today hosted the Honorable Minister of Trade, Industry and Competition, Mr Ebrahim Patel who officially opened Aspen’s world class general anaesthetics production line at its Gqeberha-based flagship manufacturing site. This manufacturing capability will convert Aspen’s Gqeberha facility into one of the largest manufacturing… Continue reading Minister Ebrahim Patel opens Aspen’s world class general anaesthetic manufacturing line

Aspen increases revenue from continuing operations by 12% to R37,8 billion

Stephen Saad, Aspen Group Chief Executive

Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, is pleased to report the following salient financial results for the year ended 30 June 2021: *The prior year comparatives for continuing operations have been restated to include the discontinued European business within discontinued operations in compliance with IFRS… Continue reading Aspen increases revenue from continuing operations by 12% to R37,8 billion

Stephen Saad discusses the J&J vaccine release with eNCA’s Sally Burdett

Aspen confirmed on 26 July 2021 that the first supplies to South Africa of the Johnson & Johnson COVID-19 vaccines, from the new API source located in Europe, were being released to Johnson & Johnson from its flagship Gqeberha-based manufacturing site. These vaccines will be further distributed throughout South Africa in line with the various… Continue reading Stephen Saad discusses the J&J vaccine release with eNCA’s Sally Burdett

Aspen confirms release of Covid-19 vaccines to Johnson & Johnson for supply to South Africa

Durban, South Africa – Aspen, a global multinational specialty pharmaceutical company, is pleased to confirm that the first supplies to South Africa of the Johnson & Johnson COVID-19 vaccines, from the new API source located in Europe, will be released to Johnson & Johnson from its flagship Gqeberha-based manufacturing site later today. These vaccines will… Continue reading Aspen confirms release of Covid-19 vaccines to Johnson & Johnson for supply to South Africa

CNN Live – Aspen’s US$700m investment in equitable vaccine access for Africa

CNN's Julia Chatterley spoke to Stephen Saad about Aspen's US$700 m investment in vaccine supplies for Africa

“Over 90% of our vaccines are imported. A high majority from #India. When India cut off all exports, #Africa was left without vaccines.” Stephen Saad, CEO @aspenpharma discusses their recent $700M investment & ensuring future Africa supplies.

Aspen statement on manufacture and supply of COVID-19 vaccines

Durban – Aspen, a global multinational specialty pharmaceutical company, was extremely disappointed to learn over the past weekend that specific batches of the Johnson & Johnson COVID-19 vaccine manufactured at our Gqeberha production site and designated for the South African market have to be destroyed due to the Good Manufacturing Practice risk of isolated material… Continue reading Aspen statement on manufacture and supply of COVID-19 vaccines

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.